A. Meru

发表

Discovery and evaluation of novel FAAH inhibitors in neuropathic pain model.

S. Balwe, K. Mookhtiar, A. Raje, 2019, Bioorganic & medicinal chemistry letters.

Discovery of pyrazole carboxylic acids as potent inhibitors of rat long chain L-2-hydroxy acid oxidase.

A. Chugh, J. Vacca, D. Barawkar, 2012, Bioorganic & medicinal chemistry letters.

Discovery of Potent and Selective A2A Antagonists with Efficacy in Animal Models of Parkinson's Disease and Depression.

A. Chugh, S. Chaudhary, D. Barawkar, 2017, ACS medicinal chemistry letters.

Comparative in vivo uroselectivity profiles of anticholinergics, tested in a novel anesthetized rabbit model.

A. Chugh, A. Ray, J. Gupta, 2007, European journal of pharmacology.

Intermittent claudication: an overview.

A. Chugh, B. Thyagarajan, S. Mittra, 2006, Atherosclerosis.

Design and synthesis of novel, potent and selective hypoxanthine analogs as adenosine A1 receptor antagonists and their biological evaluation.

G. Bedse, S. Menon, A. Chugh, 2017, Bioorganic & medicinal chemistry.

Potent and Selective Inhibitors of Long Chain l-2-Hydroxy Acid Oxidase Reduced Blood Pressure in DOCA Salt-Treated Rats.

A. Chugh, S. Chaudhary, J. Vacca, 2011, ACS medicinal chemistry letters.

Design, Synthesis of Novel, Potent, Selective, Orally Bioavailable Adenosine A2A Receptor Antagonists and Their Biological Evaluation.

S. Menon, S. Chaudhary, D. Barawkar, 2017, Journal of medicinal chemistry.

RESEARCH PAPER AE9C90CB: a novel, bladder-selective muscarinic receptor antagonist for the treatment of overactive bladder

A. Chugh, A. Ray, Suman Gupta, 2010 .

Discovery and pharmacological evaluation of indole derivatives as potent and selective RORγt inverse agonist for multiple autoimmune conditions.

V. Kandikere, B. Kulkarni, R. Nagaraj, 2019, Bioorganic & medicinal chemistry letters.